(Q37056330)

18 August 2017

1 reference

title

Platelet activating factor as a mediator and therapeutic approach in bronchial asthma (English)

1 reference

18 August 2017

0 references

3

B Rogala

1 reference

18 August 2017

2

Z Brzoza

1 reference

18 August 2017

Alicja Kasperska-Zając

series ordinal

1

object named as

A Kasperska-Zajac

1 reference

18 August 2017

publication date

12 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

31

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

112-120

1 reference

https://scigraph.springernature.com/pub.10.1007/s10753-007-9056-9

18 August 2017

exact match

0 references

cites work

Expression of platelet-activating factor receptor mRNA in human and guinea pig lung

1 reference

https://api.crossref.org/works/10.1007%2FS10753-007-9056-9

Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-007-9056-9

Salbutamol inhibits pulmonary effects of platelet activating factor in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-007-9056-9

Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-007-9056-9

Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-007-9056-9

Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma

21 January 2018

1 reference

12 December 2020

Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen

1 reference

12 December 2020

Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice

1 reference

12 December 2020

Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs

1 reference

12 December 2020

Stimulation of degranulation from human eosinophils by platelet-activating factor

1 reference

12 December 2020

Histamine release from human leukocytes by platelet-activating factor

1 reference

12 December 2020

Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration.

1 reference

12 December 2020

Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine

1 reference

12 December 2020

Induction of IL-4 by platelet-activating factor

1 reference

12 December 2020

No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics

1 reference

12 December 2020

Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms

1 reference

12 December 2020

Inflammatory mediators of asthma: an update

1 reference

12 December 2020

Effect of platelet activating factor (PAF) on the migration of human lymphocytes

1 reference

12 December 2020

Platelet-activating factor increases the expression of metalloproteinase-9 in human bronchial epithelial cells

1 reference

12 December 2020

Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma

1 reference

12 December 2020

Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model

1 reference

12 December 2020

Basophil histamine release by platelet-activating factor in aspirin-sensitive subjects with asthma

1 reference

12 December 2020

Platelet activating factor: effects on bronchomotor tone and bronchial responsiveness in human beings.

1 reference

12 December 2020

The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma

1 reference

12 December 2020

Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects

1 reference

12 December 2020

Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.

1 reference

12 December 2020

Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation

1 reference

12 December 2020

Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219

1 reference

12 December 2020

Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction

1 reference

12 December 2020

Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

1 reference

12 December 2020

Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings

1 reference

12 December 2020

Lack of systemic oxidative stress during PAF challenge in mild asthma

1 reference

12 December 2020

Mechanism of platelet activating factor-induced vascular leakage in the rat trachea

1 reference

12 December 2020

Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation

1 reference

12 December 2020

Platelet-activating factor causes ventilation-perfusion mismatch in humans

1 reference

12 December 2020

Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses

1 reference

12 December 2020

Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors.

1 reference

12 December 2020

Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man.

1 reference

12 December 2020

Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine

1 reference

12 December 2020

Discovery and preliminary pharmacology of Sch 37370, a dual antagonist of PAF and histamine

1 reference

12 December 2020

Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man

1 reference

12 December 2020

Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma

1 reference

12 December 2020

Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils

1 reference

12 December 2020

Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response

1 reference

12 December 2020

Bronchial hyper-reactivity: recent preclinical developments.

1 reference

12 December 2020

The evidence of platelet activation in bronchial asthma

1 reference

12 December 2020

Comparison of platelet-activating factor receptor mRNA levels in peripheral blood eosinophils from normal subjects and atopic asthmatic patients

1 reference

12 December 2020

Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man

1 reference

12 December 2020

Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium

1 reference

12 December 2020

Allergen exposure in acute asthma causes the release of platelet-activating factor (PAF) as demonstrated by the desensitization of platelets to PAF

1 reference

12 December 2020

Release of PAF-acether from human blood monocytes

1 reference

12 December 2020

Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor

1 reference

12 December 2020

Enhanced production of platelet activating factor by peripheral granulocytes from children with asthma

1 reference

12 December 2020

The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction

1 reference

12 December 2020

Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma

1 reference

12 December 2020

PAF responsiveness in Japanese subjects with plasma PAF acetylhydrolase deficiency

1 reference

12 December 2020

Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma

1 reference

12 December 2020

Differential plasma duration of antiplatelet-activating factor and antihistamine activities of oral Sch 37370 in humans.

1 reference

12 December 2020

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

1 reference

12 December 2020

Platelet-activating factor enhances interleukin-6 production by alveolar macrophages

1 reference

12 December 2020

Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms.

1 reference

12 December 2020

Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons

1 reference

12 December 2020

The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils

1 reference

12 December 2020

Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy

1 reference

12 December 2020

Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study

1 reference

12 December 2020

PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils

1 reference

12 December 2020

Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen

1 reference

12 December 2020

Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions

1 reference

12 December 2020

Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children

1 reference

12 December 2020

The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma

1 reference

12 December 2020

PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro

1 reference

12 December 2020

Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro

1 reference

12 December 2020

Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation.

1 reference

12 December 2020

Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma

1 reference

12 December 2020

Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients

1 reference

12 December 2020

Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma.

1 reference

12 December 2020

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

1 reference

12 December 2020

Effect of cetirizine, a potent H1 antagonist, on platelet activating factor induced bronchoconstriction in asthma

1 reference

12 December 2020

Skin eosinophilia in atopic patients

1 reference

12 December 2020

Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses

1 reference

12 December 2020

Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage

1 reference

12 December 2020

Plasma platelet activating factor-acetylhydrolase (PAF-AH).

1 reference

12 December 2020

Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children

1 reference

12 December 2020

Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects

1 reference

12 December 2020

Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma.

1 reference

12 December 2020

Platelet-activating factor: a possible mediator of the dual response to allergen?

1 reference

12 December 2020

Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor

1 reference

12 December 2020

The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils

1 reference

12 December 2020

10.1007/S10753-007-9056-9

Identifiers

DOI

1 reference

18 August 2017

1 reference